about
BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal P...
Read More
1.22
-0.03
(-2.40%)
87,573
XNAS Volume
XNAS 23 Jan, 2026 4:02 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
BioVie Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..